3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
56
Precursor Cell Lymphoblastic Leukemia-Lymphoma
45
Myelodysplastic Syndromes
41
Leukemia, Lymphocytic, Chronic, B-Cell
30
Lymphoma, Non-Hodgkin
27
Multiple Myeloma
22
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
22
Hodgkin Disease
20
Leukemia
17
Myeloproliferative Disorders
16
Recurrence
15
Melanoma
15
Lymphoma, Follicular
15
Leukemia, Biphenotypic, Acute
15
Lymphoma, Mantle-Cell
14
Lymphoma
14
Leukemia, Myelomonocytic, Chronic
14
Lymphoma, Large B-Cell, Diffuse
13
Hematologic Neoplasms
13
Burkitt Lymphoma
11
Anemia, Refractory, with Excess of Blasts
11
Lymphoma, B-Cell, Marginal Zone
10
Lymphoma, B-Cell
10
Primary Myelofibrosis
8
Neoplasm, Residual
7
Neoplasm Metastasis
7
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
6
Neuroblastoma
6
Neoplasms
6
Graft vs Host Disease
6
Interventions
pembrolizumab
34
Cisplatin
30
Brachytherapy
16
Paclitaxel
15
Carboplatin
15
Bevacizumab
15
Radiotherapy
14
Blood Specimen Collection
13
Specimen Handling
12
Magnetic Resonance Spectroscopy
11
Colposcopy
11
Nivolumab
10
Drug Therapy
10
atezolizumab
8
Human Papillomavirus DNA Tests
8
Gemcitabine
8
lenvatinib
7
Radiation
6
Platinum
6
Biopsy
6
toripalimab
5
cemiplimab
5
Surveys and Questionnaires
5
Standard of Care
5
Radiotherapy, Intensity-Modulated
5
Practice Guidelines as Topic
5
Patient Navigation
5
Methods
5
Fulvestrant
5
Fluorodeoxyglucose F18
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Uterine Cervical Neoplasms
×
fludarabine phosphate
×
1 year
×
Clear all
No trials found.